DHD10809
Research Grade Emfizatamab
Size
£491.00
- SKU:
- DHD10809
- Additional Names:
- GNC 038, GNC-038, GNC038, CAS: 2559704-23-1
- Physical State:
- Liquid
- Purity:
- >95%
- Purification:
- Protein A/G purified from cell culture supernatant.
- Storage Conditions:
- -20[o]C Avoid freeze/thaw cycles., 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Supplier:
- AntibodySystems
- Reactivities:
- Human
- Buffer:
- 0.01M PBS, pH 7.4.
- Immunogen:
- CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain, Tumor necrosis factor receptor superfamily member 9, CD137, 4-1BB ligand receptor, CDw137, TNFRSF9, T-cell antigen ILA, T-cell antigen 4-1BB homolog, ILA
- Clone:
- Emfizatamab
- Uniprot:
- P07766, P15391, Q07011, Q9NZQ7
- Synonyms:
- 4-1BB;4-1BB ligand receptor;B-lymphocyte antigen CD19;B-lymphocyte surface antigen B4;B4;B7 homolog 1;B7-H;B7H1;CD137;CD137 antigen;CD274 antigen;CD3-epsilon;CD3e antigen, epsilon polypeptide (TiT3 complex);CD3e molecule, epsilon (CD3-TCR complex);CDw137;CVID3;differentiation antigen CD19;homolog of mouse 4-1BB;hPD-L1;ILA;IMD18;induced by lymphocyte activation (ILA);interleukin-activated receptor, homolog of mouse Ly63;PD-L1;PDCD1 ligand 1;PDCD1L1;PDCD1LG1;PDL1;programmed cell death 1 ligand 1;receptor protein 4-1BB;T cell antigen ILA;T-cell antigen 4-1BB homolog;T-cell antigen ILA;T-cell antigen receptor complex, epsilon subunit of T3;T-cell surface antigen Leu-12;T-cell surface antigen T3/Leu-4 epsilon chain;T-cell surface glycoprotein CD3 epsilon chain;T3E;TCRE;tumor necrosis factor receptor superfamily member 9
- Shipping Conditions:
- Blue Ice